Telesair, Inc. - Company Research Report

Company Overview

Name: Telesair, Inc.

Mission of the Company: Telesair, Inc. is dedicated to improving lives by transforming respiratory care through the seamless connection of hospital and home environments with advanced technology.

Founded: No information is available.

Founders: No information is available.

Key People in the Company:

• Don Lin, Ph.D. - Co-founder and Chief Executive Officer (CEO)

• Dirk Rassloff, MBA, MGM - Chief Commercial Officer with over 20 years of experience in MedTech and Pharma

• Shadi Battah, MD - Chief Medical Officer, an experienced Pulmonary and Critical Care Physician

• Randy Thurman - Management Advisor with a record of leading healthcare and pharmaceutical companies

Headquarters: 199 Technology, Suite 110, Irvine, CA 92618

Number of Employees: No information is available.

Revenue: No information is available.

Known For: Telesair is known for pioneering innovations in respiratory health technologies, notably their high-flow oxygen therapy device, Bonhawa.

Products

1. Bonhawa High Flow Oxygen Therapy (HFOT) System

Description:
The Bonhawa system is designed to address a clinical gap in providing high-flow oxygen therapy, aimed at patients with respiratory insufficiency.

Key Features:

• High Flow: Supports pediatric and adult patients, with adjustable flow rates (up to 70 L/min in the US).

• Temperature Control: Offers three settings (31ºC, 34ºC, 37ºC) for customizable therapy.

• Oxygen Supply and Monitoring: Delivers precise oxygen levels with real-time monitoring and alerts.

• Humidity: Provides constant 100% relative humidity, ensuring patient comfort.

• User Interface: Features a forward-facing touchscreen with real-time display of settings.

• Design: Minimal, smart design prioritizing ease of transport and cleaning.

• Serviceability and Upgradeability: Supported by a California-based team for maintenance and upgrades.

Consumables & Accessories:

• Heated Breathing Circuit Set

• Nasal Cannula

• Support Arm

• Medical Trolley

• Air Filter

Specifications:

• Breathing circuit offers a single-patient use for 7 days, compatible with ISO standards.

• Portable with over 90 minutes of functionality, lightweight and compact for easy transport.

Recent Developments

• FDA Clearance: On October 28, 2023, Telesair received FDA 510(k) clearance for the Bonhawa High-Flow Oxygen Therapy System.

• European CE Mark: As of August 24, 2023, the Bonhawa system received a CE mark, facilitating its availability in Europe.

• Approval in Thailand: The Bonhawa system was approved by the Thai FDA, expanding its market reach in August 2023.

Additional Information

Telesair, Inc. leverages clinical data, engineering design, software, and artificial intelligence to develop smarter respiratory solutions. The company is committed to diversity and inclusivity, focusing on delivering ease and comfort to patients, doctors, and nurses globally.

For more information, inquiries can be directed to their headquarters in Irvine, CA, with contact details provided as follows:

• Phone: 949-570-3553

• Email: service@telesair.com